You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ABOS Sale Disclosure
Porter Derrell · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$29.77K
Porter Derrell Director
ABOS
Transaction date
Jun 16, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 1 day later
ABOS daily price context
Close on/before transaction
$2.29
Jun 16, 2026
First close after public filing
$2.26
Jun 18, 2026
30-day return after filing
-0.44%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 12,800 shares @ $2.33
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-043987
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$96.1K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. ABOS | Exercise | Jun 17, 2026 | $13.95K |
| Acumen Pharmaceuticals, Inc. ABOS | Sale | Jun 17, 2026 | $30.32K |
| Acumen Pharmaceuticals, Inc. ABOS | Exercise | Jun 17, 2026 | $0 |
| Acumen Pharmaceuticals, Inc. ABOS Current | Sale | Jun 16, 2026 | $29.77K |
| Acumen Pharmaceuticals, Inc. ABOS | Exercise | Jun 15, 2026 | $6.91K |
| Acumen Pharmaceuticals, Inc. ABOS | Exercise | Jun 15, 2026 | $0 |
| Acumen Pharmaceuticals, Inc. ABOS | Sale | Jun 15, 2026 | $15.15K |